NIHR BRC Exeter - Distinguished Seminar Series: Professor Ismail

  • 9 December 2026
  • 10:30am - 12:00pm
  • Hybrid: University of Exeter St Luke's Campus, Heavitree Road, Exeter, UK and Online
  • Free to attend
Book your place

Join us for our next NIHR Biomedical Research Centre (BRC) Exeter Distinguished Speaker Seminar, featuring Professor Ismail, who will explore the concept of Mild Behavioural Impairment (MBI) as a potential marker of early cognitive decline. The seminar will provide an opportunity to learn more about this important area of brain health research and explore how changes in behaviour may help inform our understanding of cognitive decline. Attendees will have the opportunity to hear from Professor Ismail, ask questions and engage in discussion with colleagues from across the research community.

Event details

Date: Wednesday 9 December 2026

Time: 10:30am–12:00pm

Location: Room 3.06, South Cloisters, St Luke’s Campus, University of Exeter.

Format: Hybrid – attend in person or online

Refreshments: Tea, coffee and gluten-free refreshments will be available on arrival from 10:30am for those attending in person.

About the speaker


Zahinoor Ismail MD FRCPC

Dr. Ismail is a Clinician Scientist and Professor of Psychiatry, Neurology, Epidemiology, and Pathology at the Hotchkiss Brain Institute and O’Brien Institute for Public Health, at the University of Calgary. He has certification in Behavioral Neurology & Neuropsychiatry, and Geriatric Psychiatry, and has over 20 years of clinical experience. Dr. Ismail Chairs the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, which generates clinical dementia guidelines, and the Canadian Conference on Dementia, Canada’s biennial dementia clinical and research meeting.

His research program encompasses:

  1. rating scale development and measurement-based care;
  2. epidemiology and diagnosis of neurocognitive disorders;
  • nosology, assessment, and management of non-cognitive markers of dementia;
  1. neuroimaging and biomarker studies of dementia and predementia syndromes;
  2. dementia clinical trials. His research has been funded by Brain Canada, the Canadian Consortium on Neurodegeneration in Aging, and the Canadian Institutes of Health Research.

Brief description of the PROTECT UoE study:

PROTECT | Clinical and Biomedical Sciences | University of Exeter

This event is open to colleagues and researchers interested in brain health, cognitive decline and biomedical research.

Registration is required for both in-person and online attendance. Please indicate your preferred attendance option when registering.

Register here